Literature DB >> 32531269

Pan-Cancer Early Detection: Hype or Hope?

Sudhir Srivastava1, Sam Hanash2.   

Abstract

Universal cancer screening based on circulating DNA, proteins, metabolites, or other combinations has the potential to revolutionize early cancer detection, especially for cancers with no available screening modalities. Two recent publications in Science and Annals of Oncology highlight the potential benefits and limitations of single-test, multiple cancer screens. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID： 32531269     DOI： 10.1016/j.ccell.2020.05.021

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  2 in total

1.  A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing.

Authors:  Boshen Jiao; Roman Gulati; Hormuzd A Katki; Philip E Castle; Ruth Etzioni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09-20       Impact factor: 4.090

2.  GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.

Authors:  Guoming Chen; Dongqiang Luo; Nan Zhong; Danyun Li; Jiyuan Zheng; Hui Liao; Zhuoyao Li; Xiaoxiao Lin; Qiqi Chen; Cheng Zhang; Yuanjun Lu; Yau-Tuen Chan; Qing Ren; Ning Wang; Yibin Feng
Journal:  Front Immunol       Date:  2022-03-08       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.